Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) was up 53.3% during mid-day trading on Friday . The company traded as high as $0.4165 and last traded at $0.4165. Approximately 171 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 974 shares. The stock had previously closed at $0.2717.
Zelira Therapeutics Stock Performance
The business has a 50 day simple moving average of $0.25 and a 200 day simple moving average of $0.25.
Zelira Therapeutics Company Profile
Zelira Therapeutics Ltd is a clinical-stage biotechnology company focused on the development and commercialization of proprietary cannabinoid-based therapies. The company leverages a portfolio of clinical and preclinical drug candidates designed to address unmet medical needs in areas such as chronic pain, autism spectrum disorder, Alzheimer’s disease and sleep disorders. Utilizing patented formulation and delivery platforms, Zelira aims to optimize efficacy and safety profiles of plant-derived cannabinoids.
The company pursues a dual geography strategy through its Australian and North American operations.
Featured Articles
- Five stocks we like better than Zelira Therapeutics
- What a Former CIA Agent Knows About the Coming Collapse
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- NEW LAW: Congress Approves Setup For Digital Dollar?
- New Banking Law #1582 Could Unlock $21 Trillion for Americans
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
